Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Expanded and reorganized the study's site information by adding a generic Locations section and listing sites in California, Massachusetts, New Jersey, and New York. The previous state-specific location blocks were removed.
    Difference
    0.6%
    Check dated 2025-12-23T12:36:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed on the page, replacing the previous v3.3.1. This appears to be a minor site version update without changes to the study content, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2025-12-01T16:56:07.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces the previous Revision: v3.2.0 on the page, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:44:06.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating status notice.
    Difference
    0.4%
    Check dated 2025-11-17T06:31:17.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Screenshots show minor visual and layout updates to the Study Details page without changes to inclusion criteria, interventions, outcomes, or important dates.
    Difference
    0.5%
    Check dated 2025-11-03T01:11:03.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Key updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).
    Difference
    4%
    Check dated 2025-10-05T10:01:20.000Z thumbnail image

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.